Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl- tRNA(Sec) required for selenoprotein biosynthesis (By similarity). Additionally we are shipping Src-Like-Adaptor Proteins (6) and Src-Like-Adaptor Kits (3) and many more products for this protein.
Showing 10 out of 21 products:
SLAP and SLAP2 are critical inhibitors of platelet (hem)ITAM signaling in the setting of arterial thrombosis and ischemic stroke
SLAP is a critical regulator of B-cell development and function and its deficiency leads to decreased autoreactive B cells that are otherwise maintained by inefficient receptor editing or failed negative selection.
Src-like adaptor protein (SLAP) functions as a negative regulator of the granulocyte-macrophage colony-stimulating factor receptor (show CSF2RA Antibodies) (GM-CSFR (show CSF2RA Antibodies)) generation of monocyte-derived dendritic cells of bone marrow origin.
SLAP deficiency dramatically reduces both the incidence and severity of arthritis and prevents development of chronic arthritis in the double SKG (mutant ZAP70 (show ZAP70 Antibodies)) Src-like adapter protein (SLAP) knockout mouse model.
SLAP negatively regulates differentiation of osteoclasts and proliferation of their precursors.
SLAP functions in a pathway that requires the phosphorylated TCRzeta (show CD247 Antibodies) chain and the Src (show SRC Antibodies) family kinase Lck (show LCK Antibodies), but not ZAP-70 (show ZAP70 Antibodies) (zeta-associated protein of 70 kD).
SLAP has a conserved function in B and T cells by adapting c-Cbl (show CBL Antibodies) to the antigen-receptor complex and targeting it for degradation
SECp43 (show TRNAU1AP Antibodies) and SLA (show HEPH Antibodies) have roles in selenoprotein synthesis [soluble liver antigen]
overexpression of SLalpha and SLbeta enhanced transcription of IGFs, insulin (show INS Antibodies), leptin (show LEP Antibodies), sterol regulatory element binding protein 1 (show SREBF1 Antibodies), and fatty acid synthase (show FASN Antibodies), as well as expression of vitellogenin (show VTG Antibodies) and proopiomelanocortin (show POMC Antibodies) in transgenic larvae
results suggest that cytoplasm-specific transduction of the SH3 and SH2 domains of SLAP has a therapeutic potential of being an immunosuppressive reagent for the treatment of various autoimmune diseases
Taken together the data demonstrate that SLAP negatively regulates wild-type c-Kit (show KIT Antibodies) signaling, but not its oncogenic counterpart, indicating a possible mechanism by which the oncogenic c-Kit (show KIT Antibodies) bypasses the normal cellular negative feedback control
upon ligand stimulation SLAP stably associates with Flt3 (show FLT3 Antibodies) through multiple phosphotyrosine residues in Flt3 (show FLT3 Antibodies). SLAP mRNA is differentially expressed in different cancers and its expression significantly increased in patients carrying the Flt3 (show FLT3 Antibodies)-ITD mutation
These data provide evidence for src-like adaptor protein-dependent regulation of CD3 zeta-chain in the fine control of TCR signaling.
Although SLA is a prominent glucocorticoids response gene, it does not seem to contribute to the anti-leukemic effects of glucocorticoids.
The SLA molecule and its functionally relevant residues have been highly conserved throughout the evolution.
Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl- tRNA(Sec) required for selenoprotein biosynthesis (By similarity).
, O-phosphoseryl-tRNA(Sec) selenium transferase
, UGA suppressor tRNA-associated protein
, sec synthase
, selenocysteine synthase
, selenocysteinyl-tRNA(Sec) synthase
, sep-tRNA:Sec-tRNA synthase
, src-like-adapter protein 1
, src-like adapter protein
, src-like adaptor protein
, src-like adaptor